Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) Other Operating Expenses (2016 - 2020)

Edesa Biotech's Other Operating Expenses history spans 8 years, with the latest figure at $1.2 million for Q3 2020.

  • For Q3 2020, Other Operating Expenses changed N/A year-over-year to $1.2 million; the TTM value through Jun 2021 reached $1.2 million, up 19243.7%, while the annual FY2020 figure was $17601.0, N/A changed from the prior year.
  • Other Operating Expenses for Q3 2020 was $1.2 million at Edesa Biotech, up from $3778.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.2 million in Q3 2020 and bottomed at -$896617.0 in Q1 2019.
  • The 5-year median for Other Operating Expenses is $137446.0 (2017), against an average of $120775.9.
  • The largest annual shift saw Other Operating Expenses surged 200.76% in 2016 before it tumbled 740.23% in 2019.
  • A 5-year view of Other Operating Expenses shows it stood at $163400.0 in 2016, then tumbled by 38.28% to $100851.0 in 2017, then plummeted by 174.98% to -$75623.0 in 2018, then soared by 105.0% to $3778.0 in 2019, then skyrocketed by 30364.53% to $1.2 million in 2020.
  • Per Business Quant, the three most recent readings for EDSA's Other Operating Expenses are $1.2 million (Q3 2020), $3778.0 (Q4 2019), and $2172.0 (Q2 2019).